Electrochemical immunosensing of low-density lipoprotein based on sol-gel encapsulation

Detalhes bibliográficos
Autor(a) principal: Nascimento do Egito, Elton Max
Data de Publicação: 2023
Outros Autores: Morales Frias, Isaac Aaron, Oliveira, Maria D.L., Andrade, Cesar
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/212204
Resumo: Lipoprotein monitoring is desirable in the management of medical conditions such as atherosclerotic cardiovascular disease and coronary artery disease, in which controlling the concentration of these chylomicrons is crucial. Current clinical methods are complex and present poor reproducibility between laboratories. For these reasons, recent guidelines discard the assessment of low-density lipoprotein cholesterol (LDL-C) as a routine analysis during lipid-lowering therapies. Concerning the importance of monitoring this parameter, the authors present an electrochemical immunosensor constructed from a simple and easy-to-reproduce platform that allows detecting and quantifying LDL nanoparticles directly from human serum samples. The performance of the biosensor was studied by scanning electron microscopy, cyclic voltammetry, and electrochemical impedance spectroscopy. The biosensing platform displays good stability and linearity between 30 mg dL-1 and 135 mg dL-1 with a detection limit of 20 mg dL-1. The proposed biosensor can be easily employed for monitoring LDL concentration in clinical treatments.
id USP-31_ebd35f840fff5079912f3d9e47299fe3
oai_identifier_str oai:revistas.usp.br:article/212204
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Electrochemical immunosensing of low-density lipoprotein based on sol-gel encapsulationApolipoproteinBiosensor; ElectrochemistryHypercholesterolemiaSelf-assembled monolayerSol-gelLipoprotein monitoring is desirable in the management of medical conditions such as atherosclerotic cardiovascular disease and coronary artery disease, in which controlling the concentration of these chylomicrons is crucial. Current clinical methods are complex and present poor reproducibility between laboratories. For these reasons, recent guidelines discard the assessment of low-density lipoprotein cholesterol (LDL-C) as a routine analysis during lipid-lowering therapies. Concerning the importance of monitoring this parameter, the authors present an electrochemical immunosensor constructed from a simple and easy-to-reproduce platform that allows detecting and quantifying LDL nanoparticles directly from human serum samples. The performance of the biosensor was studied by scanning electron microscopy, cyclic voltammetry, and electrochemical impedance spectroscopy. The biosensing platform displays good stability and linearity between 30 mg dL-1 and 135 mg dL-1 with a detection limit of 20 mg dL-1. The proposed biosensor can be easily employed for monitoring LDL concentration in clinical treatments.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2023-05-15info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/21220410.1590/s2175-97902023e22430Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023)Brazilian Journal of Pharmaceutical Sciences; v. 59 (2023)Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023)2175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/212204/194318Copyright (c) 2023 Brazilian Journal of Pharmaceutical Scienceshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessNascimento do Egito, Elton MaxMorales Frias, Isaac Aaron Oliveira, Maria D.L.Andrade, Cesar2023-05-24T17:42:03Zoai:revistas.usp.br:article/212204Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2023-05-24T17:42:03Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Electrochemical immunosensing of low-density lipoprotein based on sol-gel encapsulation
title Electrochemical immunosensing of low-density lipoprotein based on sol-gel encapsulation
spellingShingle Electrochemical immunosensing of low-density lipoprotein based on sol-gel encapsulation
Nascimento do Egito, Elton Max
Apolipoprotein
Biosensor; Electrochemistry
Hypercholesterolemia
Self-assembled monolayer
Sol-gel
title_short Electrochemical immunosensing of low-density lipoprotein based on sol-gel encapsulation
title_full Electrochemical immunosensing of low-density lipoprotein based on sol-gel encapsulation
title_fullStr Electrochemical immunosensing of low-density lipoprotein based on sol-gel encapsulation
title_full_unstemmed Electrochemical immunosensing of low-density lipoprotein based on sol-gel encapsulation
title_sort Electrochemical immunosensing of low-density lipoprotein based on sol-gel encapsulation
author Nascimento do Egito, Elton Max
author_facet Nascimento do Egito, Elton Max
Morales Frias, Isaac Aaron
Oliveira, Maria D.L.
Andrade, Cesar
author_role author
author2 Morales Frias, Isaac Aaron
Oliveira, Maria D.L.
Andrade, Cesar
author2_role author
author
author
dc.contributor.author.fl_str_mv Nascimento do Egito, Elton Max
Morales Frias, Isaac Aaron
Oliveira, Maria D.L.
Andrade, Cesar
dc.subject.por.fl_str_mv Apolipoprotein
Biosensor; Electrochemistry
Hypercholesterolemia
Self-assembled monolayer
Sol-gel
topic Apolipoprotein
Biosensor; Electrochemistry
Hypercholesterolemia
Self-assembled monolayer
Sol-gel
description Lipoprotein monitoring is desirable in the management of medical conditions such as atherosclerotic cardiovascular disease and coronary artery disease, in which controlling the concentration of these chylomicrons is crucial. Current clinical methods are complex and present poor reproducibility between laboratories. For these reasons, recent guidelines discard the assessment of low-density lipoprotein cholesterol (LDL-C) as a routine analysis during lipid-lowering therapies. Concerning the importance of monitoring this parameter, the authors present an electrochemical immunosensor constructed from a simple and easy-to-reproduce platform that allows detecting and quantifying LDL nanoparticles directly from human serum samples. The performance of the biosensor was studied by scanning electron microscopy, cyclic voltammetry, and electrochemical impedance spectroscopy. The biosensing platform displays good stability and linearity between 30 mg dL-1 and 135 mg dL-1 with a detection limit of 20 mg dL-1. The proposed biosensor can be easily employed for monitoring LDL concentration in clinical treatments.
publishDate 2023
dc.date.none.fl_str_mv 2023-05-15
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/212204
10.1590/s2175-97902023e22430
url https://www.revistas.usp.br/bjps/article/view/212204
identifier_str_mv 10.1590/s2175-97902023e22430
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/212204/194318
dc.rights.driver.fl_str_mv Copyright (c) 2023 Brazilian Journal of Pharmaceutical Sciences
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2023 Brazilian Journal of Pharmaceutical Sciences
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023)
Brazilian Journal of Pharmaceutical Sciences; v. 59 (2023)
Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023)
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1800222918107463680